<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "ranitidine inj VIAL">
<dose><value>50</value>
<value>0.125</value>
<value>0.15</value>
<value>0.175</value>
<value>0.2</value>
<value>0.225</value>
<value>0.25</value>
<value>1</value>
<value>1.5</value>
<value>2</value>
<value>2.5</value>
</dose>
<route><value>IM</value>
<value>IV</value>
<value>IV </value>
</route>
<strength><value>25 mg/mL</value>
</strength>
<frequency><value>Q6H</value>
<value>Q8H</value>
<value>ONCE</value>
<value>CONTINUOUS</value>
</frequency>
<instruction><value>Administer 1 hour pre-operatively.</value>
<value>Administer by continuous infusion for stress ulcer prophylaxis</value>
<value>Administer by continuous infusion for hypersecretory conditions.</value>
<value>DAY 1 of 21. If oral ranitidine has not been taken by patient as instructed, administer 30 minutes pre-PACLitaxel. May be administered by PO route.</value>
<value>DAY 1 of 21. May be administered by PO route.</value>
<value>DAY 1 of 7. If oral ranitidine has not been taken by patient as instructed, administer 30 minutes pre-PACLitaxel. May be administered by PO route.</value>
<value>DAY 1 of 7. May be administered by PO route.</value>
</instruction>
<volume><value>2 mL</value>
<value>40 mL</value>
</volume>
<units><value>mg</value>
<value>mg/kg/hour</value>
</units>
<Population><value>Adjuvant PACLitaxel/CARBOplatin. Non-Small Cell Lung Cancer</value>
<value>PACLitaxel / CARBOplatin. Advanced / Metastatic Non-Small Cell Lung Cancer</value>
<value>PACLitaxel/CARBOplatin (Weekly) and concurrent RT. Non-Small Cell Lung Cancer.</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>stress ulcer prophylaxis</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=1685</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=1686</value>
</BackgroundInformation>
<PRNInformation><value>YES</value>
</PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>